Busulfan dosing in children with BMIs ≥85% undergoing HSCT: A new optimal strategy

Brittan Browning, Kimberly Thormann, Amy Donaldson, Terri Halverson, Marie Shinkle, Morris Kletzel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Busulfan dosing in children with BMIs ≥85% undergoing HSCT: A new optimal strategy'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science